We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVD
576
DELISTED
COVANCE INC.
CVD
$3.79M 0.02%
36,472
+1,184
+3% +$117K
CEMP
577
DELISTED
Cempra, Inc.
CEMP
$3.78M 0.02%
327,552
+117,401
+56% +$1.46M
TER icon
578
Teradyne
TER
$52B
$3.78M 0.02%
190,000
-40,000
-17% -$774K
ECOM
579
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$3.77M 0.02%
100,000
-4,000
-4% -$172K
WPS
580
DELISTED
iShares International Developed Property ETF
WPS
$3.76M 0.02%
103,220
+2,030
+2% +$73.8K
TIF
581
DELISTED
Tiffany & Co.
TIF
$3.76M 0.02%
+43,600
New +$3.87M
SLCA
582
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$3.74M 0.02%
98,000
-7,000
-7% -$225K
OII icon
583
Oceaneering
OII
$4.75B
$3.74M 0.02%
52,000
-186,000
-78% -$13.3M
VMRK
584
Vivmark Residential
VMRK
$50.8B
$3.73M 0.02%
64,400
+770
+1% +$43.4K
EOPN
585
DELISTED
E2OPEN INC COM STK (DE)
EOPN
$3.72M 0.02%
+158,000
New +$3.98M
SNA icon
586
Snap-on
SNA
$19.4B
$3.7M 0.02%
32,600
ESL
587
DELISTED
Esterline Technologies
ESL
$3.7M 0.02%
34,700
-5,000
-13% -$527K
CMS icon
588
CMS Energy
CMS
$20.7B
$3.68M 0.02%
125,662
-12,068
-9% -$334K
EXEL icon
589
Exelixis
EXEL
$14.1B
$3.68M 0.02%
1,039,070
-19,493
-2% -$133K
ETP
590
DELISTED
Energy Transfer Partners, L.P.
ETP
$3.63M 0.02%
80,000
COL
591
DELISTED
Rockwell Collins
COL
$3.62M 0.02%
45,400
-7,990
-15% -$628K
MAS icon
592
Masco
MAS
$13.6B
$3.59M 0.02%
183,901
-1,845,278
-91% -$36.4M
CLB icon
593
Core Laboratories
CLB
$563M
$3.57M 0.02%
18,000
-1,000
-5% -$189K
LLL
594
DELISTED
L3 Technologies, Inc.
LLL
$3.57M 0.02%
30,200
MBT
595
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$3.55M 0.02%
202,792
-17,375
-8% -$310K
THO icon
596
Thor Industries
THO
$3.71B
$3.54M 0.02%
58,022
-6,100
-10% -$339K
NTRS icon
597
Northern Trust
NTRS
$32.7B
$3.53M 0.02%
53,900
+15,400
+40% +$956K
CVG
598
DELISTED
Convergys
CVG
$3.53M 0.02%
161,200
-47,645
-23% -$989K
RRC icon
599
Range Resources
RRC
$9.79B
$3.53M 0.02%
42,498
+39,931
+1,556% +$3.4M
CTRA
600
DELISTED
Coterra Energy
CTRA
$3.51M 0.02%
103,488
-36,089
-26% -$1.33M

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.